Detalles de la búsqueda
1.
Fixed-duration venetoclax plus obinutuzumab improves quality of life and geriatric impairments in FCR-unfit patients with CLL.
Blood
; 142(13): 1131-1142, 2023 09 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-37363833
2.
Persistent symptoms of fatigue, neuropathy and role-functioning impairment among indolent non-Hodgkin lymphoma survivors: A longitudinal PROFILES registry study.
Br J Haematol
; 197(5): 590-601, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35365860
3.
Clinical impact of assessing thrombus age using magnetic resonance venography prior to catheter-directed thrombolysis.
Eur Radiol
; 32(7): 4555-4564, 2022 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-35347362
4.
Reduced incidence of vein occlusion and postthrombotic syndrome after immediate compression for deep vein thrombosis.
Blood
; 132(21): 2298-2304, 2018 11 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-30237155
5.
Treatment of patients with MYC rearrangement positive large B-cell lymphoma with R-CHOP plus lenalidomide: results of a multicenter HOVON phase II trial.
Haematologica
; 105(12): 2805-2812, 2020 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-33256379
6.
Changes in body weight and serum liver tests associated with parenteral nutrition compared with no parenteral nutrition in patients with acute myeloid leukemia during remission induction treatment.
Support Care Cancer
; 28(9): 4381-4393, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31916008
7.
Neoadjuvant chemotherapy with or without anthracyclines in the presence of dual HER2 blockade for HER2-positive breast cancer (TRAIN-2): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 19(12): 1630-1640, 2018 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-30413379
8.
Medical nutrition therapy during intensive remission-induction treatment and hematopoietic stem cell transplantation in acute myeloid leukemia patients: Hematologists' experiences and perspectives.
Clin Nutr ESPEN
; 57: 399-409, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37739686
9.
Prognostic Value of FLT3-Internal Tandem Duplication Residual Disease in Acute Myeloid Leukemia.
J Clin Oncol
; 41(4): 756-765, 2023 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36315929
10.
R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Lancet Haematol
; 10(12): e966-e975, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-37922925
11.
Ixazomib, daratumumab and low-dose dexamethasone in intermediate-fit patients with newly diagnosed multiple myeloma: an open-label phase 2 trial.
EClinicalMedicine
; 63: 102167, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37680948
12.
Comparing Survivors of Cancer in Population-Based Samples With Those in Online Cancer Communities: Cross-sectional Questionnaire Study.
JMIR Cancer
; 8(1): e19379, 2022 Mar 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-35258460
13.
Nutrition-related problems, nutritional support practices and barriers to adherence to nutritional guidelines during intensive treatment for acute myeloid leukemia: Patients' and hematology nurses' perspectives and experiences.
Clin Nutr ESPEN
; 48: 446-455, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35331527
14.
Combining Ixazomib With Subcutaneous Rituximab and Dexamethasone in Relapsed or Refractory Waldenström's Macroglobulinemia: Final Analysis of the Phase I/II HOVON124/ECWM-R2 Study.
J Clin Oncol
; 40(1): 40-51, 2022 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34388022
15.
Venetoclax consolidation after fixed-duration venetoclax plus obinutuzumab for previously untreated chronic lymphocytic leukaemia (HOVON 139/GiVe): primary endpoint analysis of a multicentre, open-label, randomised, parallel-group, phase 2 trial.
Lancet Haematol
; 9(3): e190-e199, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35240075
16.
Clofarabine added to intensive treatment in adult patients with newly diagnosed ALL: the HOVON-100 trial.
Blood Adv
; 6(4): 1115-1125, 2022 02 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34883506
17.
CAVA (Ultrasound-Accelerated Catheter-Directed Thrombolysis on Preventing Post-Thrombotic Syndrome) Trial: Long-Term Follow-Up Results.
J Am Heart Assoc
; 10(11): e018973, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34032127
18.
Three-Year Follow-up of Neoadjuvant Chemotherapy With or Without Anthracyclines in the Presence of Dual ERBB2 Blockade in Patients With ERBB2-Positive Breast Cancer: A Secondary Analysis of the TRAIN-2 Randomized, Phase 3 Trial.
JAMA Oncol
; 7(7): 978-984, 2021 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34014249
19.
Addition of lenalidomide to intensive treatment in younger and middle-aged adults with newly diagnosed AML: the HOVON-SAKK-132 trial.
Blood Adv
; 5(4): 1110-1121, 2021 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33616652
20.
Adherence to guidelines on nutrition support during intensive treatment of acute myeloid leukemia patients: A nationwide comparison.
Clin Nutr ESPEN
; 39: 242-250, 2020 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-32859324